GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
GeneDx announced GenomeDx Prenatal™, a whole genome sequencing test that delivers fast, comprehensive insights when fetal anomalies are identified.
Objectives: Fetal fibronectin (fFN) testing between the 24th and 34th weeks of pregnancy in patients with symptomatic preterm labor (PTL) helps assess the risk of spontaneous preterm birth (sPTB), yet ...
The NIPT (noninvasive prenatal testing) is a genetic test performed on pregnant women, in order to detect fetal chromosomal aneuploidies. It is based upon the testing of cell-free fetal DNA (cf-fDNA) ...
During a pregnancy, women are offered prenatal genetic screening and diagnostic testing to determine whether a fetus is healthy or has certain genetic disorders or anomalies. This information can help ...
Please can you give an overview of the causes of preterm labor. Preterm birth is the most significant issue facing pregnant women and the clinicians caring for them. With each preterm delivery, a ...
“Prenatal testing can be a very important and emotional decision for parents,” Dr. Wick says. “If the infant has a lethal condition, discussion should include monitoring during labor (for example, a ...
Globally, NIPT is seeing increasing uptake across hospitals and diagnostic laboratories as demand for safer, early fetal screening rise and prenatal care pathways continue to evolve globally helping ...
LONDON - JULY 18: (Photo illustration by Daniel Berehulak/Getty Images) Over time, non-invasive screening studies were developed that were easier and safer for pregnant patients. Early versions of ...
Health authorities earlier named 2 Hong Kong-based companies linked to alleged smuggling of blood samples for gender testing A business claiming to offer fetal gender testing is advertising for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results